Exela Technologies, Inc. (XELA) announced on March 9 that the company received a new $90 contract with a major US health insurance company. Exela Technologies is a global leader in business process automation and launched its PCH Global platform in September 2020 to combine its services with the power of automation technology and SaaS. This […]
Read more...
The February 2021 scorecard for the signals generated from Sonal can be downloaded here. For more information regarding how you can trade these signals, see the article The Three Moves for Event Based Trading Try Sonal 30 days for free and cancel anytime! Subscribe here and check out the Quickstart Guide
Read more...
On March 2, KemPharm, Inc. (KMPH) announced that the FDA approved its New Drug Application (NDA) for the drug AZSTARYS™ (formerly referred to as KP415). The drug is a once-daily treatment for patients six-years-old and above who have attention deficit hyperactivity disorder (ADHD). AZSTARYS™ should be available as early as the second half of 2021 […]
Read more...